Featured Research

from universities, journals, and other organizations

Doctors Reverse Kidney Failure In An HIV-Infected Patient

Date:
September 18, 1998
Source:
University Of Maryland Medical Center
Summary:
In the first documented case of its kind, doctors at the University of Maryland Medical Center have been able to reverse kidney failure in an HIV-infected patient by putting the patient on highly active, triple-drug antiretroviral therapy.

In the first documented case of its kind, doctors at the University of Maryland Medical Center have been able to reverse kidney failure in an HIV-infected patient by putting the patient on highly active, triple-drug antiretroviral therapy. This case, published in the September 5, 1998, issue of The Lancet, provides the first evidence of a connection between highly active antiretroviral therapy and a dramatic improvement in kidney function in an AIDS patient who had started dialysis. It also suggests that the therapy may eliminate the need for long-term dialysis in HIV patients, although more study is needed.

"It has been the feeling among doctors who treat HIV patients that current antiretroviral therapy may help prevent kidney failure, but it had never been documented," said Emilio Ramos, M.D., a nephrologist at the University of Maryland Medical Center and associate professor at the University of Maryland School of Medicine. "Now we are beginning a study to look at patients with HIV and kidney disease to determine whether they could benefit from highly active antiretroviral therapy."

About 10 percent of patients with HIV infection develop kidney failure. Dr. Ramos says the antiretroviral therapy will not reverse kidney failure in patients who have been on dialysis for a long time and whose kidneys have deteriorated. He believes it is most effective in the early stages of kidney failure, as was the case with this particular patient.

The patient, a 37-year-old African-American male, was unaware of his HIV status when he first came to the medical center. A kidney biopsy revealed that his kidney failure was HIV-related. One week before going on dialysis, he was put on therapy of 20 mg of stavudine a day, 50 mg of larnivudine a day and 1,250 mg of nelfinavir twice daily.

Thirteen weeks later, the patient's kidneys regained normal function and hemodialysis was stopped. In addition, the patient's viral load decreased from more than 900,000 copies/ml to 500 copies/ml. A repeat kidney biopsy also revealed that inflammation on the kidney had almost completely disappeared.

"This case is encouraging, because it implies that even a late stage complication of HIV, such as kidney failure, can be reversed with these powerful drugs. It provides more hope for our patients," says Lori Fantry, M.D., an AIDS specialist at the University of Maryland Medical Center and assistant professor of medicine at the University of Maryland School of Medicine.

"Antiviral medications cost about $10,000 per year. They are very expensive but keeping a patient on dialysis for the rest of his life is also very costly," says Ravinder K. Wali, M.D., lead author of the article and fellow in the Division of Nephrology at the University of Maryland Medical Center. "This case showed that therapy may eliminate the need for long-term dialysis in some HIV patients." Dialysis costs more than $40,000 per year.


Story Source:

The above story is based on materials provided by University Of Maryland Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Maryland Medical Center. "Doctors Reverse Kidney Failure In An HIV-Infected Patient." ScienceDaily. ScienceDaily, 18 September 1998. <www.sciencedaily.com/releases/1998/09/980918071441.htm>.
University Of Maryland Medical Center. (1998, September 18). Doctors Reverse Kidney Failure In An HIV-Infected Patient. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/1998/09/980918071441.htm
University Of Maryland Medical Center. "Doctors Reverse Kidney Failure In An HIV-Infected Patient." ScienceDaily. www.sciencedaily.com/releases/1998/09/980918071441.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins